← All companies

IDXX

IDEXX Laboratories, Inc.

IDXX Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$567.84

+9.04 +1.62%

Key statistics

from XBRL data in SEC filings

Market cap

$44.8B

Revenue (TTM)

$4.45B

Net income (TTM)

$1.10B

EPS (TTM)

$13.59

P/E ratio

41.8

Dividend yield

—

Free cash flow

$1.06B

Cash

$201M

Total assets

$3.39B

Gross margin

62.1%

52-week range

$518.55 – $769.98

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Director or officer change Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 20, 2026 8-K Director or officer change Feb 13, 2026 8-K Results of operations (earnings release) Feb 2, 2026 8-K Director or officer change; Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement; Took on a direct financial obligation Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Director or officer change Oct 7, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Director or officer change Jul 10, 2025 8-K Amended charter or bylaws; Shareholder vote results May 9, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Director or officer change Feb 14, 2025 8-K Results of operations (earnings release) Feb 3, 2025 8-K Director or officer change Dec 12, 2024 8-K Other events Dec 9, 2024 8-K Director or officer change; Regulation FD disclosure Nov 21, 2024 8-K Director or officer change Nov 12, 2024 8-K Entered a material agreement Nov 6, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K/A Results of operations (earnings release) Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Shareholder vote results May 10, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Results of operations (earnings release) May 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 5, 2024 8-K Director or officer change Dec 7, 2023 10-Q Quarter ended 2023-09-30 Nov 1, 2023 8-K Results of operations (earnings release) Nov 1, 2023 10-Q Quarter ended 2023-06-30 Aug 1, 2023